Skip to content

Stock prices for Kellanova skyrocket by 16%

Stock prices for Kellanova, the manufacturer of Pringles, have risen by 16%. The question is, should you invest?

Stock prices of Kellanova experienced a significant climb, increasing by 16%
Stock prices of Kellanova experienced a significant climb, increasing by 16%

Stock prices for Kellanova skyrocket by 16%

In a move aimed at diversifying its brand portfolio and combating challenges in the global consumer market, Mars, one of the world's largest privately held companies with annual sales exceeding $50 billion, is preparing to buy Kellanova, the maker of popular snack brands such as Pringles, Pop Tarts, and Cheez-It.

The potential acquisition, which is expected to be one of the year's biggest takeovers, has been discussed as a significant size and impact on the food industry. The financial logic of the deal could yield nearly $1 billion of synergies.

The news comes at a time when the price of cocoa has spiked to historic levels this year and its outlook remains uncertain. This acquisition would help Mars, known for its chocolate brands, to move away from its heavy reliance on cocoa.

Kellanova, with more than 150,000 employees, has appeared to weather the slowdown in US consumer spending and has been a standout performer this year. Its shares had gained 15% this year before the bid, and the company raised its full-year sales forecasts last week after its latest earnings surpassed expectations.

The potential acquisition would face less regulatory scrutiny than other brands due to less overlap with Kellanova. This is a textbook defense strategy when the market is getting tougher, as bulking up to take a bigger piece of it allows companies to better navigate the challenges.

However, some analysts, including Jennifer Saba on Breakingviews, suggest that the timing of the deal may seem odd due to shoppers becoming more discerning on price. Companies such as Procter & Gamble, McDonald's, and even Amazon have noted that consumers are becoming more price-conscious. Additionally, anti-obesity drugs from Novo Nordisk, Eli Lilly, and others pose a threat to the consumption of empty-calorie treats like those produced by Kellanova.

This article was first published in the website's magazine. Exclusive early access to news, opinion, and analysis from the team of financial experts can be enjoyed with a website subscription. Other potential acquirers for Kellanova include Mondelez International. The Ferrero company is currently planning the takeover of Kellanova, making it one of the largest takeover offers of the year.

In conclusion, the potential acquisition of Kellanova by Mars could be a strategic move to diversify its brand portfolio and navigate the challenging consumer market. However, the deal faces potential challenges from price-conscious consumers and the increasing popularity of anti-obesity drugs. Only time will tell how this acquisition will impact both companies and the wider food industry.

Read also: